HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Powers, C. Articles by Gardner, K. Search for Related Content PubMed PubMed Citation Articles by Powers, C. Articles by Gardner, K. Social Bookmarking                      What's this?

Volume 271, Number 47, Issue of November 22, 1996 pp. 30089-30095
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Modulation of JunD·AP-1 DNA Binding Activity by AP-1-associated Factor 1 (AF-1)

(Received for publication, May 29, 1996, and in revised form, September 10, 1996)

From the Laboratory of Pathology, NCI, National Institutes of Health, Bethesda, Maryland 20892

AP-1-associated factor 1 (AF-1), is a novel protein complex that dramatically enhances the assembly of JunD-containing dimers onto AP-1 consensus sites. We describe the partial purification of AF-1 from nuclear extracts of the T-cell line MLA 144 by ionic, hydrophobic and gel filtration chromatography. AF-1 is a DNA-binding protein composed of low molecular mass polypeptides of 7-17 kDa that exists in solution as a 34-kDa complex. JunD interactions with DNA are accelerated in the presence of AF-1 through the formation of a true tri-molecular complex with JunD dimers and DNA that assembles much more rapidly on DNA than JunD alone. DNA binding analysis of AF-1 interaction with JunD·AP-1 and DNA shows that AF-1 increases the DNA binding affinity of JunD for AP-1 sites over 100-fold. DNA cleavage footprint analysis of isolated AF-1·JunD DNA complexes shows that the ternary complex makes nearly twice as many contacts with DNA than JunD dimers alone. AF-1 interacts readily, but differentially with Jun homodimers and Jun·Fos heterodimers. These findings distinguish AF-1 as a significant protein-specific modulator of AP-1·JunD in T-cells.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Chmura, X. Bai, M. Nakamura, P. Kandasamy, M. McGibney, K. Kuronuma, H. Mitsuzawa, D. R. Voelker, and E. D. Chan Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L220 - L230. [Abstract] [Full Text] [PDF]

				J. L. Smith, I. Collins, G. V. R. Chandramouli, W. G. Butscher, E. Zaitseva, W. J. Freebern, C. M. Haggerty, V. Doseeva, and K. Gardner Targeting Combinatorial Transcriptional Complex Assembly at Specific Modules within the Interleukin-2 Promoter by the Immunosuppressant SB203580 J. Biol. Chem., October 17, 2003; 278(42): 41034 - 41046. [Abstract] [Full Text] [PDF]

				S. Chaudhry, W. J. Freebern, J. L. Smith, W. G. Butscher, C. M. Haggerty, and K. Gardner Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene J. Immunol., December 15, 2002; 169(12): 6767 - 6778. [Abstract] [Full Text] [PDF]

				V. Poulaki, C. S. Mitsiades, A. M. Joussen, A. Lappas, B. Kirchhof, and N. Mitsiades Constitutive Nuclear Factor-{kappa}B Activity Is Crucial for Human Retinoblastoma Cell Viability Am. J. Pathol., December 1, 2002; 161(6): 2229 - 2240. [Abstract] [Full Text] [PDF]

				N. Mitsiades, C. S. Mitsiades, V. Poulaki, D. Chauhan, P. G. Richardson, T. Hideshima, N. C. Munshi, S. P. Treon, and K. C. Anderson Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications Blood, May 29, 2002; 99(12): 4525 - 4530. [Abstract] [Full Text] [PDF]

				N. Mitsiades, C. S. Mitsiades, V. Poulaki, D. Chauhan, P. G. Richardson, T. Hideshima, N. Munshi, S. P. Treon, and K. C. Anderson Biologic sequelae of nuclear factor-kappa B blockade in multiple myeloma: therapeutic applications Blood, May 13, 2002; 99(11): 4079 - 4086. [Abstract] [Full Text] [PDF]

				Q. Li, K. Gardner, L. Zhang, B. Tsang, F. Bostick-Bruton, and E. Reed Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells J. Biol. Chem., September 4, 1998; 273(36): 23419 - 23425. [Abstract] [Full Text] [PDF]

				W. G. Butscher, C. Powers, M. Olive, C. Vinson, and K. Gardner Coordinate Transactivation of the Interleukin-2 CD28 Response Element by c-Rel and ATF-1/CREB2 J. Biol. Chem., January 2, 1998; 273(1): 552 - 560. [Abstract] [Full Text] [PDF]

				H. Yasui, W. Butscher, M. Cohen, N. Spriggs, R. Wersto, E. C. Kohn, L. Liotta, and K. Gardner Selective Inhibition of Mitogen-induced Transactivation of the HIV Long Terminal Repeat by Carboxyamidotriazole. CALCIUM INFLUX BLOCKADE REPRESSES HIV-1 TRANSCRIPTIONAL ACTIVATION J. Biol. Chem., November 7, 1997; 272(45): 28762 - 28770. [Abstract] [Full Text] [PDF]

				M. Olive, D. Krylov, D. R. Echlin, K. Gardner, E. Taparowsky, and C. Vinson A Dominant Negative to Activation Protein-1 (AP1) That Abolishes DNA Binding and Inhibits Oncogenesis J. Biol. Chem., July 25, 1997; 272(30): 18586 - 18594. [Abstract] [Full Text] [PDF]

				W. G. Butscher, C. M. Haggerty, S. Chaudhry, and K. Gardner Targeting of p300 to the Interleukin-2 Promoter via CREB-Rel Cross-talk during Mitogen and Oncogenic Molecular Signaling in Activated T-cells J. Biol. Chem., July 13, 2001; 276(29): 27647 - 27656. [Abstract] [Full Text] [PDF]

				N. V. Kumar and L. R. Bernstein Ten ERK-related Proteins in Three Distinct Classes Associate with AP-1 Proteins and/or AP-1 DNA J. Biol. Chem., August 17, 2001; 276(34): 32362 - 32372. [Abstract] [Full Text] [PDF]